A federal aviation safety inspector has filed a $12.75 million lawsuit against United Airlines, alleging the carrier banned him for life after he documented cabin safety violations during a 2022 flight, leading to professional repercussions and a dismissed federal case against him.
Zurn Elkay Water Solutions (NYSE: ZWS) closed its fiscal year on a high note, surpassing revenue and profit forecasts for the fourth quarter of 2025. The company's focus on operational discipline and growth in institutional markets helped drive a nearly 10% sales increase.
Despite a five-year decline in earnings, Frontline plc (NYSE:FRO) shares have rallied sharply this week, buoyed by dividend growth and revenue increases, prompting a closer look at the metrics driving this apparent disconnect.
Fox Corporation's second-quarter revenue climbed to $5.18 billion, surpassing analyst forecasts, fueled by strength in cable programming and a resilient advertising market despite a dip in political ad spending.
Yum! Brands Inc. (NYSE: YUM) edged past Wall Street forecasts for its fourth quarter, fueled by robust same-store sales at Taco Bell and record KFC expansion. While revenue climbed 6% to $2.51 billion, the market reaction was muted as investors weigh the fast-food giant's growth trajectory against a challenging consumer environment.
Old Dominion Freight Line sees glimmers of a demand rebound in manufacturing data and inventory trends but warns the road to recovery may be uneven, with a clearer inflection point potentially years away.
With a decade of market-beating returns, American Express's unique business model continues to attract investors. But can this financial stalwart sustain its growth amid regulatory threats and a shifting economic landscape?
Despite posting quarterly results that exceeded analyst expectations, shares of Boston Scientific and AbbVie fell sharply as investors scrutinized underperformance in key business units and expressed caution over forward-looking statements.
Mortgage insurer Enact Holdings (ACT) reported solid fourth-quarter results, surpassing earnings expectations and outlining a significant shareholder return program, as disciplined expense management and resilient credit metrics bolster confidence.
Elon Musk has consolidated his space exploration and artificial intelligence ventures, merging SpaceX and xAI in a landmark transaction that creates a single entity valued at approximately $1.25 trillion. The move signals a strategic pivot to intertwine AI development with interplanetary ambition, though it raises immediate questions about regulatory oversight and market concentration.
United Community Banks (UCB) posted stronger-than-expected quarterly revenue, driven by loan growth and improved margins. The regional lender's share repurchase program and debt management moves are drawing investor attention as its stock outperforms the broader market year-to-date.
As Arm Holdings prepares to report its Q3 FY2026 results, the semiconductor design giant stands at a crossroads. Investors are looking beyond recent stock volatility for signs that its licensing momentum and AI strategy can justify a premium valuation in a choppy market.
Shares of AST SpaceMobile surged over 10% following Elon Musk's comments positioning space infrastructure as a cost-effective foundation for future AI development, highlighting the growing synergy between the space and artificial intelligence sectors.
In a Morning Joe appearance, FT columnist Ed Luce cited newly released documents suggesting Jeffrey Epstein's network had 'deep coordination' with Russian officials, highlighting a 2016 meeting with a former Russian ambassador and Peter Thiel.
The killing of Seif al-Islam Gaddafi, son of the late Libyan leader, in Zintan has sent shockwaves through a nation already fractured by conflict. Analysts are divided on the political impact of his death but agree it removes a potent, if dormant, symbol from Libya's turbulent landscape.
Barclays and Scotiabank have raised their price targets for Teva Pharmaceutical following its better-than-expected Q4 2025 results and a key pediatric approval for its migraine drug AJOVY, signaling growing confidence in the generic drugmaker's turnaround trajectory.
Industrial components maker Kadant Inc. (KAI) has finalized a €157 million deal to acquire Austrian precision parts manufacturer voestalpine BÖHLER Profil, a key supplier for over three decades. While the acquisition strengthens Kadant's consumables-focused strategy and secures critical patented technology, executives caution that accounting complexities and existing inventory will dilute earnings through much of 2026 before margin benefits materialize.
While PPL's stock has trailed the broader market over the past year, recent quarterly beats and a stable regulatory profile have analysts maintaining a 'Moderate Buy' stance, albeit with tempered near-term expectations.
IT solutions giant CDW (NASDAQ:CDW) reported stronger-than-expected fourth-quarter results for 2025, with revenue rising 6.3% to $5.51 billion and adjusted EPS of $2.57 surpassing forecasts. The performance underscores resilient corporate IT spending despite broader economic uncertainties.
Life sciences firm Azenta (AZTA) edged past Wall Street's revenue expectations for its fiscal fourth quarter, though year-over-year sales remained stagnant. While adjusted earnings met consensus, the company's long-term growth trajectory and path to sustained profitability remain key investor concerns.
